Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e493dbb326bdb84242fbc9af833f128e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
filingDate |
1988-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff226c6c5e5467387794ed14d29d5a9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d90962a3718025e649ec7502161e85 |
publicationDate |
1989-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0299668-A1 |
titleOfInvention |
Pharmaceutical composition containing ibuprofen |
abstract |
A high content of 2-(4-isobutylphenyl)propionic acid is achieved in a pharmaceutical composition by solidifying molten 2-(4-isobutylphenyl)propionic acid to provide a unit dose composition. The composition may be prepared by heating the 2-(4-isobutylphenyl)propionic acid until molten, optionally mixing with pharmaceutically acceptable excipients, forming into a unit dosage presentation and allowing the composition to solidify. Preferably the composition contains greater than 80% ibuprofen or S(+)-ibuprofen and is filled into a hard gelatin capsule. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0473604-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-401871-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9631197-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0473604-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9410993-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2293099-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5525355-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0478838-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5807574-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9520382-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9014073-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0381182-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0381182-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1175913-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0398287-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-637782-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5869101-A |
priorityDate |
1987-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |